BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 15865875)

  • 1. Diagnosis of polycythemia vera based on bone marrow pathology.
    Thiele JM; Kvasnicka HM
    Curr Hematol Rep; 2005 May; 4(3):218-23. PubMed ID: 15865875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2001 Apr; 86(4):368-74. PubMed ID: 11325641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic impact of bone marrow histopathology in polycythemia vera (PV).
    Thiele J; Kvasnicka HM
    Histol Histopathol; 2005 Jan; 20(1):317-28. PubMed ID: 15578448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow features of diagnostic impact in erythrocytosis.
    Thiele J; Kvasnicka HM; Diehl V
    Ann Hematol; 2005 Jun; 84(6):362-7. PubMed ID: 15803315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
    Michiels JJ; Juvonen E
    Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis?
    Thiele J; Kvasnicka HM
    Curr Hematol Malig Rep; 2006 Jun; 1(2):87-92. PubMed ID: 20425337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients.
    Thiele J; Kvasnicka HM; Muehlhausen K; Walter S; Zankovich R; Diehl V
    Pathol Res Pract; 2001; 197(2):77-84. PubMed ID: 11261821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
    Michiels JJ
    Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis.
    Thiele J; Kvasnicka HM; Zankovich R; Diehl V
    Haematologica; 2000 Nov; 85(11):1126-34. PubMed ID: 11064463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.
    Mossuz P; Girodon F; Donnard M; Latger-Cannard V; Dobo I; Boiret N; Lecron JC; Binquet C; Barro C; Hermouet S; Praloran V
    Haematologica; 2004 Oct; 89(10):1194-8. PubMed ID: 15477203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow biopsy (BMB). II. Bone marrow biopsy in myeloproliferative disorders.
    Macavei I; Galatâr N
    Morphol Embryol (Bucur); 1989; 35(2):117-27. PubMed ID: 2529429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
    Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
    Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ Polyglobuly versus polycythemia vera].
    Thiele J; Kvasnicka HM
    Pathologe; 2000 Jan; 21(1):24-30. PubMed ID: 10663666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).
    Michiels JJ; Thiele J
    Int J Hematol; 2002 Aug; 76(2):133-45. PubMed ID: 12215011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary (essential) thrombocythemia versus polycythemia vera rubra. A histomorphometric analysis of bone marrow features in trephine biopsies.
    Thiele J; Zankovich R; Schneider G; Kremer B; Fischer R; Diehl V
    Anal Quant Cytol Histol; 1988 Oct; 10(5):375-82. PubMed ID: 3207462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patho-anatomical features of the bone marrow.
    Lennert K; Nagai K; Schwarze EW
    Clin Haematol; 1975 Jun; 4(2):331-51. PubMed ID: 1102191
    [No Abstract]   [Full Text] [Related]  

  • 17. Myelofibrosis--what's in a name? Consensus on definition and EUMNET grading.
    Thiele J; Kvasnicka HM
    Pathobiology; 2007; 74(2):89-96. PubMed ID: 17587880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow sections in the differential diagnosis of polycythemia.
    Kurnick JE; Ward HP; Block MH
    Arch Pathol; 1972 Dec; 94(6):489-99. PubMed ID: 5086062
    [No Abstract]   [Full Text] [Related]  

  • 19. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
    Kvasnicka HM; Thiele J
    Pathobiology; 2007; 74(2):63-71. PubMed ID: 17587877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow histopathology in the diagnosis of chronic myeloproliferative disorders: a forgotten pearl.
    Thiele J; Kvasnicka HM; Vardiman J
    Best Pract Res Clin Haematol; 2006; 19(3):413-37. PubMed ID: 16781481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.